|
Market Closed -
Nasdaq
23:30:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.530 USD | -2.55% |
|
+5.52% | -77.16% |
| 11/09/25 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 01/04/25 | GRI Bio Prices up to $13 Million Equity Offering | MT |
| Market Cap | 5.39M 4.83M 4.44M 4.03M 7.52M 512M 7.67M 52.98M 21.27M 269M 20.24M 19.81M 849M | P/E 2021 |
-4.2x | P/E 2022 | -0.42x |
|---|---|---|---|---|---|
| Enterprise Value | 1.61M 1.44M 1.33M 1.2M 2.25M 153M 2.29M 15.84M 6.36M 80.51M 6.05M 5.92M 254M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
-
| Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -2.55% | ||
| Current month | -77.16% | ||
| Current year | -77.16% |
| 5 years | 1.45 |  | 256.2 |
| 10 years | 1.45 | | 310.8 |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -9.3M -8.33M -7.66M -6.94M -12.98M -883M -13.22M -91.39M -36.69M -465M -34.91M -34.17M -1.47B | -7.02M -6.29M -5.79M -5.24M -9.8M -667M -9.98M -69M -27.7M -351M -26.36M -25.8M -1.11B |
| Net Debt | -7.34M -6.57M -6.05M -5.48M -10.24M -697M -10.43M -72.12M -28.95M -367M -27.55M -26.96M -1.16B | -3.78M -3.39M -3.11M -2.82M -5.28M -359M -5.37M -37.14M -14.91M -189M -14.19M -13.89M -596M |
Employees
-
Sector
-
| Date | Price | Change |
|---|---|---|
| 30/10/26 | $1.530 | -2.55% |
| 29/10/26 | $1.570 | -3.38% |
| 28/10/26 | $1.625 | +2.85% |
| 27/10/26 | $1.580 | +5.33% |
| 26/10/26 | $1.500 | +3.45% |
- Stock Market
- Stocks
- GRI Stock
Select your edition
All financial news and data tailored to specific country editions
